We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$18.9B
AUM Growth
+$3.55B
Cap. Flow
+$2.11B
Cap. Flow %
11.15%
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179

Sector Composition

Rank Sector Weight
1 Healthcare 25.08%
2 Technology 23.91%
3 Financials 10.59%
4 Consumer Discretionary 9.42%
5 Industrials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANRO icon
1076
Alto Neuroscience
ANRO
$1.06B
-359,873
Closed -$777K
INR
1077
Infinity Natural Resources
INR
$243M
-40,000
Closed -$750K
WBTN
1078
WEBTOON Entertainment Inc
WBTN
$1.28B
-1,140,800
Closed -$8.75M
SW
1079
Smurfit Westrock
SW
$24.6B
-41,772
Closed -$1.88M
TWFG
1080
TWFG Inc
TWFG
$355M
-51,674
Closed -$1.6M
FLOC
1081
Flowco Holdings
FLOC
$843M
-50,000
Closed -$1.28M
XYZ
1082
Block Inc
XYZ
$48.8B
-277,300
Closed -$15.1M
LAR
1083
Lithium Argentina AG
LAR
$1.01B
-1,614,729
Closed -$3.46M
TTAM
1084
Titan America SA
TTAM
$2.92B
-150,000
Closed -$2.03M
SNDK
1085
Sandisk
SNDK
$192B
-30,958
Closed -$1.47M
KLRS
1086
Kalaris Therapeutics
KLRS
$94.2M
-21,519
Closed -$173K
BERY
1087
DELISTED
Berry Global Group, Inc.
BERY
-224,910
Closed -$15.7M
FNA
1088
DELISTED
Paragon 28, Inc.
FNA
-325,292
Closed -$4.25M
PDCO
1089
DELISTED
Patterson Companies, Inc.
PDCO
-360,000
Closed -$11.2M
ITCI
1090
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-123,750
Closed -$16.3M

Similar funds

Woodline Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.

  • Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
  • Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
  • Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
  • Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
  • Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
  • Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
  • Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.

Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.